Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Treatment of Pain Associated With Fibromyalgia: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Pain Associated With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02187159).
- Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Treatment of Peripheral T-cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Peripheral T-cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01664975).
- Treatment of Psychotic Major Depression With Mifepristone: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Psychotic Major Depression With Mifepristone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00867360).
- Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate: Complete Statistical AnalysisIndependent statistical analysis of Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04006925).
- Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Treatment of Severe Childhood Aggression (The TOSCA Study): Complete Statistical AnalysisIndependent statistical analysis of Treatment of Severe Childhood Aggression (The TOSCA Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00796302).
- Treatment of Sleep-disordered Breathing in Patients With SCI: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Sleep-disordered Breathing in Patients With SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02830074).
- Treatment of Smoking Lapses and Relapses: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Smoking Lapses and Relapses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01807871).
- Treatment of the Face and Neck With Lower Ulthera System Energy Settings: Complete Statistical AnalysisIndependent statistical analysis of Treatment of the Face and Neck With Lower Ulthera System Energy Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Treatment of Upper Extremity Deep-Vein Thrombosis: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Upper Extremity Deep-Vein Thrombosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00245856).
- Treatment Outcomes for Ankle Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Treatment Outcomes for Ankle Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00391365).
- Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.: Complete Statistical AnalysisIndependent statistical analysis of Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.: primary endpoint results, effect…
- Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00704379).
- Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Treatment With AMD3100 (Plerixafor) in Non-Hodgkin’s Lymphoma and Multiple Myeloma Patients: Complete Statistical AnalysisIndependent statistical analysis of Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Treatment With Intravitreal Avastin for Large Uveal Melanomas: Complete Statistical AnalysisIndependent statistical analysis of Treatment With Intravitreal Avastin for Large Uveal Melanomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00596362).
- Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative Pain: Complete Statistical AnalysisIndependent statistical analysis of Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03327220).
- Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients: Complete Statistical AnalysisIndependent statistical analysis of Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00342563).
- Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy: Complete Statistical AnalysisIndependent statistical analysis of Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- Treatment-Resistant Depression Registry: Complete Statistical AnalysisIndependent statistical analysis of Treatment-Resistant Depression Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00320372).
- TREATNOWIndependent statistical analysis of Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04372628).
- TREATTIndependent statistical analysis of TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03136445).
- TREC-BDIndependent statistical analysis of Treatment to Enhance Cognition in Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01470781).
- TreeToppIndependent statistical analysis of Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Treg Modulation With CD28 and IL-6 Receptor Antagonists: Complete Statistical AnalysisIndependent statistical analysis of Treg Modulation With CD28 and IL-6 Receptor Antagonists: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04066114).
- TRENDIndependent statistical analysis of Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Trental & Vitamin E for Radiation-Induced Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Trental & Vitamin E for Radiation-Induced Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00583700).
- TREO_MSIndependent statistical analysis of Time Restricted Eating Outcomes in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04389970).
- Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TrevisioPASIndependent statistical analysis of Trevisio Post-Approval Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04433520).
- TRFIndependent statistical analysis of Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism: Complete Statistical AnalysisIndependent statistical analysis of Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction: Complete Statistical AnalysisIndependent statistical analysis of Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs): Complete Statistical AnalysisIndependent statistical analysis of Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From…
- Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions: Complete Statistical AnalysisIndependent statistical analysis of Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00574587).
- Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT): Complete Statistical AnalysisIndependent statistical analysis of Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00094497).
- Trial of Adherence App for Buprenorphine Treatment (TAAB) Study: Complete Statistical AnalysisIndependent statistical analysis of Trial of Adherence App for Buprenorphine Treatment (TAAB) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03779997).
- Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Trial of an Inactivated Yellow Fever Virus Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Trial of an Inactivated Yellow Fever Virus Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05172544).
- Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size…
- Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…